News
12 Health Care Stocks Moving In Friday's After-Market Session
26 Apr 24
Movers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
25 Apr 24
Movers
Compass Therapeutics Receives FDA Fast Track Designation For The Investigation Of CTX-009 In Combination With Paclitaxel For The Treatment Of Patients With Metastatic Or Locally Advanced Biliary Tract Tumors That Have Been Previously Treated
25 Apr 24
Biotech, News, FDA, General
HC Wainwright & Co. Reiterates Buy on Compass Therapeutics, Maintains $10 Price Target
16 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Compass Therapeutics Presents Data Demonstrating Elimination Of MHC Class I Negative Tumors In Models At 2024 AACR Annual Meeting
9 Apr 24
Biotech, News, General
Wedbush Reiterates Outperform on Compass Therapeutics, Maintains $8 Price Target
22 Mar 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Compass Therapeutics, Maintains $10 Price Target
21 Mar 24
News, Price Target, Analyst Ratings
Compass Therapeutics Q4 EPS $(0.11) Misses $(0.09) Estimate
21 Mar 24
Earnings, News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
13 Mar 24
Movers
12 Health Care Stocks Moving In Tuesday's After-Market Session
5 Mar 24
Movers
12 Health Care Stocks Moving In Tuesday's After-Market Session
27 Feb 24
Movers
Press releases
Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in Combination with Paclitaxel for the Treatment of Patients with Metastatic or Locally Advanced Biliary Tract Tumors That Have Been Previously Treated
25 Apr 24
Health Care, Press Releases
Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference
12 Apr 24
News, Press Releases
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
9 Apr 24
Press Releases
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
21 Mar 24
Biotech, Earnings, Press Releases, General